ASCO 2019: No benefit from pazopanib in advanced kidney cancer after surgery to remove metastases
The E2810 research study was conducted to determine whether taking the oral drug pazopanib following…
Browsing: Kidney Cancer
Heavier and taller children are more likely to develop kidney cancer as adults than their average-sized peers
A study of more than 300,000 individuals in Denmark, presented at this year’s European Congress…
Study may explain why immunotherapy not effective for some patients with metastatic melanoma and kidney cancer
White blood cells known as B cells have been shown to be effective for predicting…
ASCO GU 2019: Pembrolizumab Plus Axitinib Extended Overall Survival and Progression-Free Survival Versus Current Standard Treatment for Advanced Kidney Cancer
Results from the randomized, phase III KEYNOTE-426 clinical trial show that first-line therapy with a…
Recurring infections could lead to delayed bladder or kidney cancer diagnosis
Women with bladder or kidney cancer may lose out on a prompt diagnosis if they…
High-dose radiation therapy improves long-term survival in patients with stage-IV cancers
The first report from a phase II, multi-centre clinical trial indicates that a newer and…
Cancer has a biological clock and this drug may keep it from ticking
A new drug shows potential to halt cancer cells’ growth by stunting the cells’ biological…
Personalised treatment benefits kidney cancer patients
Personalised treatment plans may extend life expectancy for early-stage kidney cancer patients who have risk…
Research review underscores progress in treating kidney cancer, importance of close patient monitoring
With the swift introduction of approved immunotherapy approaches into the treatment landscape for many cancers,…
ESMO 2018: Avelumab plus axitinib significantly improve PFS in untreated renal cell carcinoma
A combination of the immune checkpoint blocker, , plus the tyrosine kinase inhibitor (TKI), axitinib,…